Figure 8.
T1-weighted images of the stomach taken using saline solution as the negative control (left) and 5 minutes after the oral administration of the PEG-coated Gd@PBNP suspension (right), showing a significant enhancement of the positive contrast (i.e. T1-weighted) of MRI signals in the stomach